Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject

United States News News

Johnson & Johnson Pauses Covid-19 Vaccine Trials Due to Sick Subject
United States Latest News,United States Headlines
  • 📰 WSJ
  • ⏱ Reading Time:
  • 11 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 8%
  • Publisher: 63%

Johnson & Johnson paused all trials of its Covid-19 vaccine, including a final-stage U.S. study, after a volunteer had an unexplained illness

Johnson & Johnson said it has paused further dosing in all clinical trials of its experimental Covid-19 vaccine because a study volunteer had an unexplained illness.

The pause announced Monday affects all trials of J&J’s vaccine, including a large Phase 3 trial that began in September and aimed to enroll up to 60,000 people in the U.S. and several other countries.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

WSJ /  🏆 98. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Johnson & Johnson pauses coronavirus vaccine trials after unexplained illnessJohnson & Johnson pauses coronavirus vaccine trials after unexplained illnessThe drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and new enrollment has been halted, citing “an...
Read more »

Johnson & Johnson coronavirus vaccine trials paused - Business InsiderJohnson & Johnson coronavirus vaccine trials paused - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Read more »

Johnson & Johnson pauses coronavirus vaccine trials after unexplained illnessJohnson & Johnson pauses coronavirus vaccine trials after unexplained illnessThe drug maker announced Monday night that the 60,000-patient, late-stage trials have been put on hold and new enrollment has been halted, citing “an...
Read more »

As globe gallops into vaccine trials, insurers remain unfazedAs globe gallops into vaccine trials, insurers remain unfazedThe world is racing towards a vaccine in record time, stirring public concerns about safety to the extent that nine leading developers have felt compelled to issue a pledge to uphold scientific standards and testing rigour.
Read more »

UK study tests if BCG vaccine protects against COVIDUK study tests if BCG vaccine protects against COVIDThe widely used BCG tuberculosis vaccine will be tested on frontline care workers in Britain for its effectiveness against COVID-19, researchers running the UK arm of a global trial said.
Read more »



Render Time: 2025-03-12 15:14:40